Trial Profile
Treat-and-extend regimen (TER) in patients with diabetic macular edema
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 12 Nov 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Aflibercept
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 12 Nov 2015 New trial record